Today, Uber, Airbnb, and Starbucks are set to release their quarterly earnings results. The picture for these three firms’ reports is predicted to be mixed.
The biotechnology and ridesharing industries have had divergent fortunes over the course of the COVID-19 pandemic. With Pfizer, Moderna, and Uber set to release Q1 2022 results in the coming days, it remains to be seen whether these trends will continue.
Major firms in the entertainment, exercise, and ride-sharing sectors are expected to reveal how their last quarter went this week. Traders might be anticipating these quarterly earnings releases to get a sense of where Disney, Peloton, Uber, and Lyft are headed in 2022.
Uber announced Q1 earnings yesterday and showed mixed results, with better than expected earnings, but a miss on revenue predictions. Gross bookings, which include both passenger related and food-related orders, were at an all-time high.
Videos & Articles help you expand your trading knowledge.
Our Economic calendar helps you explore global market events.
Understand the full costs of your trades now for better expense management later.
This information is written by Ecxmarket Ltd. The information is provided for general purposes only, and does not take into account any personal circumstances or objectives. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice. No representation or warranty is given as to the accuracy or completeness of this information. It does not constitute financial, investment or other advice on which you can rely. Any references to past performance, historical returns, future projections, and statistical forecasts are no guarantee of future returns or future performance. Ecxmarket will not be held responsible for any use that may be made of this information and for any consequences that may result from such use. Hence, any person acting based on this information does so at their own discretion. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research.
